Precision BioSciences Inc (DTIL)
9.43
-0.29
(-2.98%)
USD |
NASDAQ |
Apr 26, 16:00
9.43
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Total Liabilities (Quarterly): 140.92M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 140.92M |
| September 30, 2023 | 135.28M |
| June 30, 2023 | 147.66M |
| March 31, 2023 | 164.32M |
| December 31, 2022 | 177.74M |
| September 30, 2022 | 187.35M |
| June 30, 2022 | 194.14M |
| March 31, 2022 | 111.69M |
| December 31, 2021 | 120.33M |
| September 30, 2021 | 125.76M |
| June 30, 2021 | 129.56M |
| Date | Value |
|---|---|
| March 31, 2021 | 203.49M |
| December 31, 2020 | 105.73M |
| September 30, 2020 | 104.86M |
| June 30, 2020 | 98.59M |
| March 31, 2020 | 99.17M |
| December 31, 2019 | 96.92M |
| September 30, 2019 | 104.51M |
| June 30, 2019 | 97.94M |
| March 31, 2019 | 155.97M |
| December 31, 2018 | 98.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
96.92M
Minimum
Dec 2019
203.49M
Maximum
Mar 2021
134.00M
Average
125.76M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Altimmune Inc | 16.54M |
| BioVie Inc | 14.00M |
| Adial Pharmaceuticals Inc | 0.6531M |
| Gritstone Bio Inc | 125.92M |
| Humacyte Inc | 114.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.78M |
| Shareholders Equity (Quarterly) | 18.86M |
| Debt to Equity Ratio | 1.188 |
| Current Ratio | 2.728 |
| Net Debt Paydown Yield | -0.10% |